Publiziert in: Marktpuls
Frei

Credit Suisse Products in Subscription Dienstag, 19. März 2013 - 15:45

Products in Subscription (Issuer Credit Suisse)

 

New Issues, March 19, 2013
We are pleased to send you below an overview of our structured products currently in subscription. The Termsheets and additional product information can be accessed by visiting our webpage www.credit-suisse.com/derivatives. Please enter the respective valor number in order to find the products. The subscriptions for products can be placed with the client advisor of your bank or directly via phone under +41 (0) 44 335 76 09 *.

Thank you very much for your confidence.

Sincerely yours

Your Structured Products Team

Questions & Contacts
Credit Suisse AG Equity Derivatives Sales (ZUEA) CH-8070 Zurich Switzerland

 

For further information contact us at: Tel. +41 (0) 44 335 76 09 *Structured Products do not constitute a participation in a collective investment scheme within the meaning of the Swiss Federal Act on Collective Investment Schemes (CISA) and are therefore not subject to authorization and supervision by the Swiss Financial Market Supervisory Authority (FINMA). Investors are not protected by CISA.

New Products in Subscription
Yield Enhancement
  Description SSPA Code Issuer Underlying Ccy Issue Price Coupon/ Max Yld Barrier Feature Maturity Valor End of Subscription
8.00% p.a. on Sanofi / Total / Vivendi 1230 Credit Suisse AG, London Branch Sanofi / Total / Vivendi EUR 100% 8% 59% 02.10.2014 (1.5yrs) 20214638 26.03.2013 (7 days left)
8.50% p.a. on UBS / Deutsche Bank / JPMorgan 1230 Credit Suisse AG, London Branch UBS / Deutsche Bank / JPMorgan CHF 100% 8.5% 69% 02.10.2013 (0.5yrs) 20214636 26.03.2013 (7 days left)
7.50% p.a. on Roche / Richemont / ABB 1230 Credit Suisse AG, London Branch Roche / Richemont / ABB CHF 100% 7.5% 69% 02.10.2014 (1.5yrs) 20214637 26.03.2013 (7 days left)
Other Products in Subscription
Yield Enhancement
  Description SSPA Code Issuer Underlying Ccy Issue Price Coupon/ Max Yld Barrier Feature Maturity Valor End of Subscription
7.25% p.a. on S&P 500® / EURO STOXX 50® / Nikkei 225 / FTSE® 100 1230 Credit Suisse AG, Nassau Branch S&P 500® / EURO STOXX 50® / Nikkei 225 / FTSE® 100 GBP 100% 7.25% 60% Callable 07.04.2015 (2yrs) 19049735 27.03.2013 (8 days left)
9.50% on Gazprom / Petrobras / Suncor Energy 1230 Credit Suisse AG, London Branch Gazprom / Petrobras / Suncor Energy USD 100% 9.5% 65% 27.03.2014 (1yr) 20214634 22.03.2013 (3 days left)
8.00% p.a. on Nestlé / Swatch / Zurich 1230 Credit Suisse AG, London Branch Nestlé / Swatch / Zurich CHF 100% 8% 69% 29.09.2014 (1.5yrs) 20214635 22.03.2013 (3 days left)
9.25% p.a. on Galenica 1230 Credit Suisse AG, London Branch Galenica CHF 100% 9.25% 79% 26.09.2013 (0.5yrs) 20214631 21.03.2013 (2 days left)
6.75% on Credit Suisse Group 1230 Credit Suisse AG, London Branch Credit Suisse Group CHF 100% 6.75% 69% 26.03.2014 (1yr) 20214633 21.03.2013 (2 days left)
7.50% p.a. on Coca-Cola / McDonald's / Starbucks 1230 Credit Suisse AG, London Branch Coca-Cola / McDonald's / Starbucks USD 100% 7.5% 69% 26.09.2014 (1.5yrs) 20214630 21.03.2013 (2 days left)
7.25% p.a. on Roche / Bayer / Pfizer 1230 Credit Suisse AG, London Branch Roche / Bayer / Pfizer CHF 100% 7.25% 69% 26.09.2014 (1.5yrs) 20214629 21.03.2013 (2 days left)
7.15% p.a. on Siemens / Bayer / SAP 1230 Credit Suisse AG, London Branch Siemens / Bayer / SAP EUR 100% 7.15% 69% 25.09.2014 (1.5yrs) 20214628 20.03.2013 (1 day left)
6.25% p.a. on Swisscom / Swiss Re / Richemont 1230 Credit Suisse AG, London Branch Swisscom / Swiss Re / Richemont CHF 100% 6.25% 59% 25.03.2015 (2yrs) 20214627 20.03.2013 (1 day left)
8.50% p.a. on ABB / Lonza / Schindler 1230 Credit Suisse AG, London Branch ABB / Lonza / Schindler CHF 100% 8.5% 69% 25.09.2014 (1.5yrs) 20214626 20.03.2013 (1 day left)
10.00% p.a. on Daimler / Volkswagen / BMW 1230 Credit Suisse AG, London Branch Daimler / Volkswagen / BMW EUR 100% 10% 75% 23.09.2013 (0.5yrs) 20214623 19.03.2013 (today)
8.50% on Zurich / Swatch / Credit Suisse Group 1230 Credit Suisse AG, London Branch Zurich / Swatch / Credit Suisse Group CHF 100% 8.5% 69% 24.03.2014 (1yr) 20214625 19.03.2013 (today)
5.00% p.a. on Nestlé / Roche / Novartis 1230 Credit Suisse AG, London Branch Nestlé / Roche / Novartis CHF 100% 5% 75% 22.09.2014 (1.5yrs) 20214624 19.03.2013 (today)
Capital Protection
  Description SSPA Code Issuer Underlying Ccy Issue Price Prot. Level Part. Cap Max. Cpn pa Maturity Valor End of Subscription
95% ProNote SMI 1100 Credit Suisse AG, Nassau Branch SMI CHF 100% 95% 100% 02.04.2014 (1yr) 18599844 22.03.2013 (3 days left)
Participation
  Description SSPA Code Issuer Underlying Ccy Issue Price Part. Bonus Level Barrier Maturity Valor End of Subscription
Bonus Certificate on Energy Stocks 1320 Credit Suisse AG, Nassau Branch BG Group / Halliburton / Royal Dutch Shell CHF 1000.00 120% 59% 28.09.2015 (2.5yrs) 18599841 19.03.2013 (today)
All terms and conditions mentioned in this document are indicative only and will be confirmed or adjusted on the Initial Fixing Date.
Legend
Product issued by Credit Suisse
Product added to the list today
Ccy: Currency in which the product is traded
Coupon / Max Yld: Interest paid p.a. / maximum yield achievable for products issued at a discount
Feature: Specific product charateristics
Max Cpn: maximum interest achievable per observation period
Part.: Percentage participation in the performance of the Underlying
Prot. Level: Minimum redemption amount paid by the Issuer
SSPA-Code: Product Category according to Swiss Structured Products Association (http://www.svsp-verband.ch)
This message may contain confidential, proprietary or legally privileged information and is intended only for the use of the addressee named above. No confidentiality or privilege is waived or lost by any misstransmission. If you are not the intended recipient of this message you are hereby notified that you must not use, disseminate, copy it in any form or take any action in reliance on it. If you have received this message in error please delete it and any copies of it and notify the sender immediately. Credit Suisse Group AG and its subsidiaries reserve the right to retain, intercept and monitor any e-mail communication through its networks if legally allowed.

This document was produced by Credit Suisse AG and/or its affiliates (hereafter "CS") with the greatest of care and to the best of its knowledge and belief. Credit Suisse provides no guarantee with regard to its content and completeness and does not accept any liability for losses which might arise from making use of this information.

This document does not constitute an offer or a recommendation to buy or sell financial instruments or banking services; the relevant terms and conditions are described in the sales prospectus and summarized in the simplified prospectus in accordance with CISA. We recommend to request prior to an investment decision the complete product information, especially with respect to product specific risks, prices and fees or charges. The product information can be obtained free of charge under the telephone number mentioned herein. The prospectus requirements of Art. 652a / Art. 1156 of the Swiss Code of Obligations are not applicable.

Structured products are suitable only for investors who understand how they work and, in particular, the associated risks, and who are able to bear their financial consequences. Investors are exposed to issuer risk. The structured product's retention of value is dependent not only on the development of the value of the underlying asset, but also on the creditworthiness of the Issuer, which may change over the term of the structured product.

These structured products may include investments in indices: The underlying indices are registered trademarks and have been licensed for use (SIX Swiss Exchange as licensor for Swiss Market Index (SMI)®; McGraw-Hill Companies Inc. as licensor for S&P 500® Index; STOXX Limited Zurich as licensor for EURO STOXX 50® Index; Nikkei Inc. as licensor for Nikkei 225® Index; Deutsche Börse AG as licensor for DAX® Index and Euronext Paris S.A. as licensor for CAC 40® Index). The indices are compiled and calculated solely by licensors and the licensors shall have no liability with respect thereto. The products based on the indices are in no way sponsored, endorsed, sold or promoted by the licensors.

These structured products may include investments in Emerging Markets: Emerging Markets are located in countries that possess one or more of the following characteristics: A certain degree of political instability, relatively unpredictable financial markets and economic growth patterns, a financial market that is still at the development stage or a weak economy. Emerging markets investments usually result in higher risks such as political risks, economical risks, credit risks, exchange rate risks, market liquidity risks, legal risks, settlement risks, market risks, shareholder risk and creditor risk.

These structured products may include investments in commodities: Commodity investments are subject to greater fluctuations in value than normal investments and may lead to additional investment risks.

Neither the information provided on this website may not be sent, taken into or distributed in the United States or to any U. S. person (within the meaning of Regulation S under the US Securities Act of 1933, as amended). This document may not be reproduced either in part or in full without the written permission of Credit Suisse.

*We would like to draw your attention to the fact that telephone calls to our lines are recorded. When we receive your call, we assume that you accept this business practice.